The expression of Lin28 targeted SOX2, and HMGA2 oncogenes were also suppressed by these inhibitors, supporting that these compounds can block the pluripotency of tumor cells and suppress treatment-resistant tumor progression [44,45,46]. The gene discussed is HMGA2; the disease is neoplasm.